Chronic obstructive pulmonary disease (COPD) is an inflammatory respiratory disease characterized by reversible airflow limitation.

The patient usually have chronic cough, sputum production or dyspnea with or without history of risk factors for the disease.

The chronic airflow limitation is caused by a combination of small airways disease and parenchymal destruction.

It is a preventable & treatable disease.

Drug Information

Indication: Regular treatment of COPD including chronic bronchitis & emphysema. Accuhaler Regular treatment of asthma...

Indication: Long-term maintenance treatment of bronchospasm & dyspnoea associated w/ COPD.

Indication: Maintenance bronchodilator treatment for symptomatic relief of COPD. Add-on maintenance bronchodilator treatme...

Striverdi Respimat

Indication: Maintenance treatment in patients w/ chronic obstructive pulmonary disease (COPD).

Indication: Bronchodilator for maintenance treatment of bronchospasm associated w/ COPD including chronic bronchitis &...

Indication: Bronchodilator for maintenance treatment of bronchospasm, associated w/ COPD, including chronic bronchitis, em...

Indication: Bronchodilator for the prevention & treatment of symptoms in chronic obstructive airway disorders w/ rever...

Indication: Bronchodilator for the prevention & treatment of symptoms in chronic obstructive airway disorders w/ rever...

Dosage: Symptomatic treatment of acute asthma episodes 1 puff stat. If breathing has not improved after 5 min, a 2nd p

Indication: Management of reversible bronchospasm associated w/ obstructive airway disease in patients who require more th...

1  /  14
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Editor's Recommendations
Most Read Articles
Stephen Padilla, 09 Jan 2018
Very elderly adults have the highest rate of invasive pneumococcal diseases, according to a recent study, suggesting that age influences manifestations of this illness.
Kathlin Ambrose, 16 Oct 2015
The label of asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) should not be used when diagnosing patients displaying symptoms of both diseases says an expert. 
Greg Town, 01 Sep 2014

The temperature of a person’s exhaled breath may be a simple, non-invasive diagnostic test for non-small cell lung cancer (NSCLC), according to a study, the results of which were presented at the recent European Respiratory Society (ERS) International Congress held in Munich, Germany.

Elvira Manzano, 28 Nov 2017
The addition of the long-acting muscarinic antagonist (LAMA) tiotropium to maintenance therapy improves FEV1* and FVC** in patients with asthma, with a greater impact on FVC in those with a more severe disease, a post-hoc analysis of data from five phase III trials have shown.